Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmaton Supplement Detailing Operation Initially Targets 5,000 Physicians

This article was originally published in The Tan Sheet

Executive Summary

Pharmaton Natural Health Products is helping promote its dietary supplements by initially targeting approximately 5,000 physicians in a detailing operation that began in the fourth quarter. The sales force of 18 full-time employees is responsible for disseminating information on Pharmaton's Ginkoba, Movana and Venastat herbal supplements.

You may also be interested in...



Pharmaton Ginkoba M/E, Prostatonin Supplements Launching In September

Pharmaton Natural Health Products is rolling out two new products in September, Ginkoba M/E, a combination ginkgo biloba/ginseng product, and Prostatonin, a supplement for prostate health containing nettle root and African plum tree bark extracts.

Pharmaton Ginkoba M/E, Prostatonin Supplements Launching In September

Pharmaton Natural Health Products is rolling out two new products in September, Ginkoba M/E, a combination ginkgo biloba/ginseng product, and Prostatonin, a supplement for prostate health containing nettle root and African plum tree bark extracts.

Pharmaton Ginkoba M/E, Prostatonin Supplements Launching In September

Pharmaton Natural Health Products is rolling out two new products in September, Ginkoba M/E, a combination ginkgo biloba/ginseng product, and Prostatonin, a supplement for prostate health containing nettle root and African plum tree bark extracts.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089427

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel